Getting Started

To begin searching within the
Government Manual simply type
in a keyword or phrase
to find your match.

Office of National Drug Control Policy

Executive Office of the President, Washington, DC 20503


DIRECTORRegina M. LaBelle, Acting
Deputy DirectorRegina M. LaBelle

Chief of StaffMario Moreno
General CounselRobert Kent
Senior Policy AnalystTom Hill

Associate Directors

Associate Directors
Legislative AffairsAnne Sokolov
OutreachAriel Britt

The Office of National Drug Control Policy helps the President establish his National Drug Control Strategy objectives, priorities, and policies and makes budget, program, and policy recommendations affecting National Drug Control Program agencies.


On November 18, 1988, President Ronald W. Reagan approved Public Law 100–690 "to prevent the manufacturing, distribution, and use of illegal drugs, and for other purposes" (102 Stat. 4181). The 365-page piece of legislation contained a number of shorter acts, including the National Narcotics Leadership Act of 1988, which established the Office of National Drug Control Policy (ONDCP) in the Executive Office of the President and became effective January 21, 1989 (102 Stat. 4189). At the head of the new Office, the Act placed a Director who is assisted by a Deputy Director for Demand Reduction and a Deputy Director for Supply Reduction. The Act also created a Bureau of State and Local Affairs within the Office (102 Stat. 4181).

On October 21, 1998, President William J. Clinton approved Public Law 105–277, which made "omnibus consolidated and emergency appropriations" (112 Stat. 2681). The 920-page piece of legislation included the Office of National Drug Control Policy Reauthorization Act of 1998 (112 Stat. 2681–670). This Act of reauthorization created the new position of Deputy Director of National Drug Control Policy to assist the ONDCP Director (112 Stat. 2681–672).

On December 29, 2006, President George W. Bush approved Public Law 109–469, which also is cited as the Office of National Drug Control Policy Reauthorization Act of 2006 (120 Stat. 3502). This Act of reauthorization made amendments to the earlier Act of 1998 and contained the following reporting provision: "The Deputy Director for Demand Reduction, the Deputy Director for Supply Reduction, and the Deputy Director for State, Local, and Tribal Affairs shall report directly to the Deputy Director of the Office of National Drug Control Policy" (120 Stat. 3505).

On October 24, 2018, President Donald J. Trump approved Public Law 115–271, which also is cited as the "SUPPORT for Patients and Communities Act" (132 Stat. 3894). This 250-page piece of legislation included the Substance Abuse Prevention Act of 2018 (132 Stat. 4110), which reauthorized the ONDCP, expanded its mandate, and made other changes.

The President appoints the ONDCP Director by the advice and with the consent of the Senate. The President also appoints the Deputy Director. Both of these appointees serve at the pleasure of the President.


Codified statutory material on food and drugs has been assigned to 21 U.S.C. Subchapter I, which comprises sections 1501–1509 of chapter 20, of that title, and is dedicated to statutory material affecting the ONDCP.

Codified statutory material on food and drugs has been assigned to 21 U.S.C. Chapter 22, which comprises sections 1701–1715 of that title and is dedicated to statutory material affecting national drug control policy.

"Chapter III—Office of National Drug Control Policy," which comprises parts 1400–1499, has been assigned to 21 CFR. That CFR title contains codified rules and regulations whose content deals with the subjects of food and drugs.


The Director establishes policies, objectives, priorities, and performance measurements for the National Drug Control Program. Each year, the Director promulgates the President's National Drug Control Strategy, other related drug control strategies, supporting reports, and a program budget that the President submits to Congress. The Director advises the President on necessary changes in the organization, management, budgeting, and personnel allocation of Federal agencies that monitor drug activities. The Director also notifies Federal agencies if their policies do not comply with their responsibilities under the National Drug Control Strategy. The ONDCP also has direct programmatic responsibility for the High Intensity Drug Trafficking Areas (HIDTA) program and the Drug-Free Communities (DFC) support program.

The HIDTA program is a Federal grant program that the ONDCP administers. The program provides resources to Federal, State, local, and Tribal agencies for coordinating activities to address drug production and trafficking in designated areas nationwide.

The DFC support program is a Federal grant program that the ONDCP administers. The program provides grants to community coalitions for strengthening the local infrastructure to reduce drug use among youth and to maintain the reductions that are achieved.

Sources of Information

Archived Records

The "Guide to Federal Records in the National Archives of the United States" indicates that records of the ONDCP have been assigned to record group 581; however, that group does not have a description associated with it.

Career Opportunities

The ONDCP posts employment opportunities on

Federal Register

Significant documents and documents that the ONDCP recently published in the Federal Register are accessible online.

Freedom of Information Act (FOIA)

To any person, the FOIA gives a statutory right for obtaining access to Government information in the records of executive branch agencies. This right to access has limits, when any of nine exemptions that are contained within the statute shield the requested information from disclosure. Information on how to submit a FOIA request is available online. The ONDCP's FOIA Requester Center also provides assistance. Phone, 202-395-6622. Fax, 202-395-5543.


The above Sources of Information were updated 2–2021.